Research Article
Autologous Cytokine-Induced Killer Cell Immunotherapy Enhances Chemotherapy Efficacy against Multidrug-Resistant Tuberculosis
Table 6
Clinical test indexes between CIK plus and chemo-mono groups after treatment 1 month and 3 months.
| Clinical test indexes | Treatment 1 month | Treatment 3 months | CIK plus | Chemo-mono | value | CIK plus | Chemo-mono | value |
| Weight (kg) | | | 0.028 | | | 0.104 | WBC (109/L) | | | 0.063 | | | 0.021 | Hb (109/L) | | | 0.202 | | | 0.087 | PLT (109/L) | | | 0.12 | | | 0.044 | N0 (109/L) | | | 0.094 | | | 0.743 | L0 (109/L) | | | 0.081 | | | 0.339 | ALT5 | | | 0.429 | | | 0.203 | AST5 | | | 0.82 | | | 0.519 | TB (μmol/L) | | | 0.247 | | | 0.225 | DB (μmol/L) | | | 0.074 | | | 0.201 | ALG (g/L) | | | 0.219 | | | 0.351 | BUN (mmol/L) | | | 0.385 | | | 0.417 | UA (μmol/L) | | | 0.559 | | | 0.536 | Cr (μmol/L) | | | 0.426 | | | 0.149 | T (%) | | | 0.72 | | | 0.633 | CD4+T (%) | | | 0.129 | | | 0.565 | CD8+T (%) | | | 0.414 | | | 0.077 | B (%) | | | 0.498 | | | 0.665 | NK (%) | | | 0.652 | | | 0.531 | CD4/CD8 | | | 0.174 | | | 0.073 | L/CD45 (%) | | | 0.036 | | | 0.131 | CD14/CD45 (%) | | | 0.118 | | | 0.325 | CD8+CD28+/CD3+ (%) | | | 0.095 | | | 0.648 | CD4+CD28-/CD3+ (%) | | | 0.93 | | | 0.251 | CD8+CD28-/CD3+ (%) | | | 0.932 | | | 0.289 | CD4+CD28+/CD3+ (%) | | | 0.308 | | | 0.203 | CD4+CD25hi/CD3+ (%) | | | 0.321 | | | 0.598 | IL-1β (pg/mL) | | | — | | | 0.286 | IL-2R (U/mL) | | | 0.188 | | | 0.002 | IL-6 (pg/mL) | | | 0.609 | | | 0.63 | IL-8 (pg/mL) | | | 0.151 | | | 0.249 | IL-10 (pg/mL) | | | 0.542 | | | 0.437 | TNF-α (pg/mL) | | | 0.412 | | | 0.826 | PCT (ng/mL) | | | 0.622 | | | 136 |
|
|
WBC: white blood cell; Hb: hemoglobin; PLT: blood platelet; NO: nitric oxide; LO: liquid oxygen; ALT: alanine aminotransferase; AST: aspartate transaminase; TB: tuberculosis; DB: direct bilirubin; ALG: antilymphocyte globulin; BUN: blood urea nitrogen; UA: urinalysis; Cr: creatinine; L: lymphocyte; PCT: procalcitonin. |